Intervention

Dual-Target Antigen-Selected CAR-NK

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions13

Lead sponsors shown1

Clinical trials

1 shown

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsNCT07410494 · 2026-02-01

RECRUITING

Common conditions

Acute Myeloid Leukemia (AML)1 Breast Cancer1 Cancer1 Colorectal Cancer (Locally Advanced or Metastatic)1 Glioblastoma1 Liver Cancer1 Melanoma (Skin Cancer)1 Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma1 Non Hodgkin Lymphoma1 Non-Small Cell Lung Cancer (NSCLC)1 Ovarian Cancer1 Pancreatic Ductal Adenocarcinoma (PDAC)1 Prostate Cancer - Recurrent1

Leading sponsors

Essen Biotech1

Trial status mix

RECRUITING1

Phase mix

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.